Nanomedicines: Complex in nature and a challenge for innovator and regulator
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: BORCHARD, Gerrit (University of Geneva, Section of Pharmaceutical Sciences, Geneva, Switzerland)
- Co-author(s): Gerrit Borchard: Section of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland;, NBCD working group, Utrecht, Netherlands
Non-biological complex drugs (NBCDs) comprise different nanomedicines such as glatiromoids, liposomes, micelles or nanoparticles. The complexity of such drugs results from the pharmacological activity being depended on both, the active principle as well as the vector system. Most NBCDs are prone to be recognized by the immune system through their.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.